|
|
|
|
LEADER |
01488naa a2200337 i 4500 |
001 |
NSK01001124081 |
003 |
HR-ZaNSK |
005 |
20220114101326.0 |
007 |
ta |
008 |
220114s2019 ci d | |0|| ||eng |
035 |
|
|
|a (HR-ZaNSK)001124081
|
040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
042 |
|
|
|a croatica
|
044 |
|
|
|a ci
|c hr
|
080 |
1 |
|
|a 577
|2 2011
|
080 |
1 |
|
|a 61
|2 2011
|
100 |
1 |
|
|a Tomáš, Šálek
|4 aut
|9 HR-ZaNSK
|
245 |
1 |
0 |
|a Assessment of the degree of adherence of medical laboratories to KDIGO 2012 guideline for evaluation and management of CKD in Czechia and Slovakia /
|c Šálek Tomáš, Friedecký Bedřich, Kratochvíla Josef, Pelinková Květa, Budina Marek.
|
300 |
|
|
|b Graf. prikazi.
|
504 |
|
|
|a Bibliografija: 22 jed.
|
653 |
|
0 |
|a Laboratoriji
|a Kreatinin
|a Cistatin C
|a Glomerularna filtracija
|a Postanalitička faza
|
653 |
|
5 |
|a Češka
|a Slovačka
|
700 |
1 |
|
|a Bedřich, Friedecký
|4 aut
|9 HR-ZaNSK
|
700 |
1 |
|
|a Josef, Kratochvíla
|4 aut
|9 HR-ZaNSK
|
700 |
1 |
|
|a Květa, Pelinková
|4 aut
|9 HR-ZaNSK
|
700 |
1 |
|
|a Marek, Budina
|4 aut
|9 HR-ZaNSK
|
773 |
0 |
|
|t Biochemia medica
|x 1330-0962
|g 29 (2019), 3 ; str. 522-530
|w nsk.(HR-ZaNSK)000012576
|
776 |
0 |
|
|a Tomáš, Šálek
|t Assessment of the degree of adherence of medical laboratories to KDIGO 2012 guideline for evaluation and management of CKD in Czechia and Slovakia
|w nsk.(HR-ZaNSK)001068958
|
981 |
|
|
|b B10/19
|
998 |
|
|
|b gtao2201
|
856 |
4 |
1 |
|u https://hrcak.srce.hr/226448
|y Elektronička verzija članka
|